tranylcypromine sulfate
Drug ingredientThis chemical is an active pharmaceutical ingredient used in FDA-regulated drugs.
Where It Comes From
6 FDA-registered drug labelers
Actavis Pharma, Inc.
Advanz Pharma (US) Corp.
Novitium Pharma LLC
NURAY CHEMICALS PRIVATE LIMITED
Solco Healthcare US, LLC
Strides Pharma Science Limited
Why It Matters
Sectors
Health
Downstream Uses
Appears in 3 drug and cosmetic product listings (FDA).
- •Parnate
- •Tranylcypromine Sulfate
- •Tranylcypromine
FDA Shortage Status
Whether any manufacturer currently reports this drug as in shortage on the FDA Drug Shortages database. "Active Shortage" means at least one presentation has status "current."
No Shortage
Shortage History
Each row is a separate manufacturer's FDA shortage filing — not a timeline for the drug as a whole. Multiple "current" entries are normal: each manufacturer/NDC files independently. Status reflects the manufacturer's report; reason describes their supply situation (Available, Unavailable, or to be discontinued).
to be discontinued
Tranylcypromine Sulfate Tablet
10/21/2025Chemical Identity
CAS13492-01-8
PubChem CID11473982
DTXSIDDTXSID90928820
FormulaC18H24N2O4S
Mol. Weight364.5 g/mol
SMILESC1C(C1N)C2=CC=CC=C2.C1C(C1N)C2=CC=CC=C2.OS(=O)(=O)O
Data Sources
114739822026-04-07
https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/name/tranylcypromine sulfate/cids/JSON
Archive: data/sources/pubchem_name/tranylcypromine sulfate.json
CAS 13492-01-82026-04-25
https://open.fda.gov/data/ndc/
Archive: data/sources/fda/ndc/ndc.json
CAS 13492-01-82026-06-13
https://api.fda.gov/drug/shortages.json
Archive: data/sources/fda/shortages/shortages.json